I-2-Hydroxy-5-Methylpyridine CAS 1003-68-5 Ubunyulu ≥99.0% iPirfenidone Intermediate Factory
Ubonelelo lwabavelisi, ubunyulu obuphezulu, iMveliso yoRhwebo
Igama leKhemikhali: 2-Hydroxy-5-Methylpyridine
CAS: 1003-68-5
Igama leMchiza | I-2-Hydroxy-5-Methylpyridine |
Izithethantonye | 5-Methyl-2(1H)-Pyridinone;I-2-Hydroxy-5-Picoline;I-6-Hydroxy-3-Picoline;5-Methyl-2-Pyridinol |
Inombolo yeCAS | 1003-68-5 |
Inombolo yeCAT | RF-PI549 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C6H7NO |
Ubunzima beMolekyuli | 109.13 |
Indawo yokunyibilika | 183.0 ukuya 187.0℃ (lit.) |
Ukunyibilika | Inyibilika kwiMethanol |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Okumhlophe-kuMhlophe ukuya koMthubi wePowder yeCrystalline |
Ubunyulu | ≥99.0% |
Isiqulatho sokufuma (KF) | ≤0.50% |
Intsalela kwi-Ignition | ≤0.50% |
Nakuphi na Ukungacoceki Okukodwa | ≤0.50% |
Ukungcola ngokupheleleyo | ≤1.00% |
Izinyibilikisi ezishiyekileyo | |
n-Butanol | ≤0.30% |
I-Ethanol | ≤0.30% |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Umbindi wePirfenidone (CAS: 53179-13-8) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
I-2-Hydroxy-5-Methylpyridine (i-CAS: 1003-68-5) isetyenziswe njenge-pharmaceutical intermediate ye-Pirfenidone (CAS: 53179-13-8).I-Pirfenidone (PFD) luhlobo lwenoveli ye-pyridine ketones ene-wide-spectrum anti-fibrotic effect, ekwazi ukuthintela kunye nokubuyisela umva ukubunjwa kwe-fibrosis kunye nesiva.Yangena kwimarike eShionogi, eJapan ngo-2008 kwaye yamkelwe yi-US yokutya kunye noLawulo lweziyobisi.Lichiza lokuqala eliye ladlula kwisigaba sesi-III solingo lwezonyango (kubandakanya ukuphindaphinda, ukungakhethi, kunye nolawulo lwe-placebo) olubonise ukusebenza kwalo ekunyangeni i-idiopathic pulmonary fibrosis (IPF);ngaphezu koko, iyeza lisebenza kakuhle ekunyangeni izifo ezithile zefibrotic ezifana ne-renal interstitial fibrosis kunye ne-liver fibrosis.